- Home
- BNRG vs ADXN Comparison
BNRG vs ADXN Comparison
Compare BNRG & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNRG
- ADXN
- Stock Information
- Founded
- BNRG 2012
- ADXN 2002
- Country
- BNRG Israel
- ADXN Switzerland
- Employees
- BNRG N/A
- ADXN N/A
- Industry
- BNRG
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- BNRG
- ADXN Health Care
- Exchange
- BNRG Nasdaq
- ADXN Nasdaq
- Market Cap
- BNRG 10.0M
- ADXN 8.2M
- IPO Year
- BNRG 2022
- ADXN N/A
- Fundamental
- Price
- BNRG $1.31
- ADXN $7.45
- Analyst Decision
- BNRG
- ADXN Strong Buy
- Analyst Count
- BNRG 0
- ADXN 1
- Target Price
- BNRG N/A
- ADXN $30.00
- AVG Volume (30 Days)
- BNRG 57.2K
- ADXN 7.7K
- Earning Date
- BNRG 03-04-2025
- ADXN 04-07-2025
- Dividend Yield
- BNRG N/A
- ADXN N/A
- EPS Growth
- BNRG N/A
- ADXN N/A
- EPS
- BNRG N/A
- ADXN 0.06
- Revenue
- BNRG N/A
- ADXN $701,260.00
- Revenue This Year
- BNRG N/A
- ADXN N/A
- Revenue Next Year
- BNRG N/A
- ADXN N/A
- P/E Ratio
- BNRG N/A
- ADXN $0.89
- Revenue Growth
- BNRG N/A
- ADXN N/A
- 52 Week Low
- BNRG $0.60
- ADXN $6.67
- 52 Week High
- BNRG $3.27
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- BNRG 48.84
- ADXN 47.90
- Support Level
- BNRG $1.19
- ADXN $7.16
- Resistance Level
- BNRG $1.30
- ADXN $8.05
- Average True Range (ATR)
- BNRG 0.09
- ADXN 0.45
- MACD
- BNRG 0.00
- ADXN -0.02
- Stochastic Oscillator
- BNRG 41.38
- ADXN 51.22
About BNRG Brenmiller Energy Ltd
Brenmiller Energy Ltd is a technology company that develops, produces, markets, and sells thermal energy storage. The technology of the company allows electrification and decarbonization of the industrial industry sector for integration with renewable energy sources and further reduction of carbon emissions.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.